MedPath
HSA Approval

VACRAX I.V. FOR INFUSION 250 mg/vial

SIN10874P

VACRAX I.V. FOR INFUSION 250 mg/vial

VACRAX I.V. FOR INFUSION 250 mg/vial

April 13, 1999

ZYFAS PHARMA PTE LTD

ZYFAS PHARMA PTE LTD

Regulatory Information

ZYFAS PHARMA PTE LTD

ZYFAS PHARMA PTE LTD

Therapeutic

Prescription Only

Formulation Information

INJECTION, POWDER, FOR SOLUTION

INTRAVENOUS

Medical Information

J05AB01

aciclovir

Manufacturer Information

ZYFAS PHARMA PTE. LTD.

Aprogen Pharmaceuticals, Inc.

Active Ingredients

ACYCLOVIR

250 mg/vial

Acyclovir

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

VACRAX I.V. FOR INFUSION 250 mg/vial - HSA Approval | MedPath